- Home
- DTST vs GOVX Comparison
DTST vs GOVX Comparison
Compare DTST & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTST
- GOVX
- Stock Information
- Founded
- DTST 2001
- GOVX 2001
- Country
- DTST United States
- GOVX United States
- Employees
- DTST N/A
- GOVX N/A
- Industry
- DTST EDP Services
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- DTST Technology
- GOVX Health Care
- Exchange
- DTST Nasdaq
- GOVX Nasdaq
- Market Cap
- DTST 28.3M
- GOVX 23.8M
- IPO Year
- DTST N/A
- GOVX N/A
- Fundamental
- Price
- DTST $4.88
- GOVX $2.64
- Analyst Decision
- DTST
- GOVX Strong Buy
- Analyst Count
- DTST 0
- GOVX 5
- Target Price
- DTST N/A
- GOVX $14.20
- AVG Volume (30 Days)
- DTST 71.8K
- GOVX 772.9K
- Earning Date
- DTST 11-14-2024
- GOVX 02-27-2025
- Dividend Yield
- DTST N/A
- GOVX N/A
- EPS Growth
- DTST N/A
- GOVX N/A
- EPS
- DTST 0.02
- GOVX N/A
- Revenue
- DTST $25,143,911.00
- GOVX $3,090,161.00
- Revenue This Year
- DTST $2.57
- GOVX N/A
- Revenue Next Year
- DTST $11.16
- GOVX $150.51
- P/E Ratio
- DTST $242.41
- GOVX N/A
- Revenue Growth
- DTST 1.64
- GOVX N/A
- 52 Week Low
- DTST $2.76
- GOVX $1.09
- 52 Week High
- DTST $8.00
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- DTST 61.46
- GOVX 58.87
- Support Level
- DTST $3.98
- GOVX $2.39
- Resistance Level
- DTST $4.34
- GOVX $2.75
- Average True Range (ATR)
- DTST 0.32
- GOVX 0.18
- MACD
- DTST 0.02
- GOVX 0.03
- Stochastic Oscillator
- DTST 91.84
- GOVX 82.26
About DTST Data Storage Corporation
Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; Flagship Solutions, LLC and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.